DNA deaminases: AIDing hormones in immunity and cancer
Open Access
- 25 June 2009
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 87 (9) , 893-897
- https://doi.org/10.1007/s00109-009-0496-6
Abstract
It is well established that hormones can cause cancer, much less known is how they induce this change in our somatic cells. This review highlights the recent finding that estrogen can exert its DNA-damaging potential by directly activating DNA deaminases. This recently discovered class of proteins deaminate cytosine to uracil in DNA, and are essential enzymes in the immune system. The enhanced production of a given DNA deaminase, induced by estrogen, can lead not only to a more active immune response, but also to an increase in mutations and oncogenic translocations. Identifying the direct molecular link between estrogen and a mutation event provides us with new targets for studying and possibly inhibiting the pathological side-effects of estrogen.Keywords
This publication has 37 references indexed in Scilit:
- Estrogen directly activates AID transcription and functionThe Journal of Experimental Medicine, 2009
- DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45Cell, 2008
- AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH TranslocationsCell, 2008
- The role of estrogen in the initiation of breast cancerPublished by Elsevier ,2006
- Expression of the AID protein in normal and neoplastic B cellsBlood, 2004
- Immunity through DNA deaminationTrends in Biochemical Sciences, 2003
- Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphomaNature, 1984
- STUDIES OF THE REGULATORY EFFECTS OF THE SEX HORMONES ON ANTIBODY FORMATION AND STEM CELL DIFFERENTIATIONThe Journal of Experimental Medicine, 1972
- Influence of Sex on Immunoglobulin LevelsNature, 1967
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896